Enquiry/Quote
Ramucirumab bulk supplier for pharma manufacturers

Ramucirumab Suppliers & Bulk Manufacturers

Available Forms: Solutions for disinfection

Available Strengths: 100 mg/10 mL

Reference Brands: Cyramza (USA/India)

Category: Oncology Cancer Care

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide

Product Description:

Gastric cancer, also known as stomach cancer, is one of the most common malignancies affecting people worldwide. It ranks among the leading cancers in both men and women, with significant prevalence in regions such as East Asia, parts of Europe, and Latin America. Countries like Japan, China, and several areas in Southern and Eastern Europe report higher rates of this disease, making it an important global health concern. Differences in lifestyle, diet, environmental factors, and genetics are believed to contribute to the variation in incidence across different populations.

In the United States, gastric cancer occurs less frequently compared to some other regions, but certain populations show higher diagnosis rates. These include Hispanic-Americans, African-Americans, Asians, and Pacific Islanders compared with non-Hispanic white populations. The disease is most commonly diagnosed in older adults, with the median age at diagnosis being around the late sixties. Despite advances in detection and treatment, gastric cancer can still be challenging to manage, as it is often diagnosed at an advanced stage.

Survival outcomes depend on factors such as stage at diagnosis, overall health of the patient, and response to treatment. Ongoing research and improved therapeutic approaches continue to focus on early detection and more effective treatment options to improve long-term outcomes for patients.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ramucirumab is used for the treatment of several advanced cancers, including gastric or gastroesophageal junction cancer, metastatic colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma. It is often used alone or in combination with chemotherapy when the disease has progressed after prior treatment.

Ramucirumab is a fully human monoclonal antibody produced using recombinant DNA technology in mammalian cell culture systems. It is designed to specifically target vascular endothelial growth factor receptor-2 (VEGFR-2).

The primary trade name of Ramucirumab is Cyramza.

Ramucirumab (Cyramza) is developed and marketed by Eli Lilly and Company.

The generic name is Ramucirumab.

The main brand name is Cyramza.

Ramucirumab is manufactured in GMP-certified biologics manufacturing facilities approved by regulatory authorities such as the US FDA, EMA, and other international agencies, depending on the region of supply.

Related Products

Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Idelalisib

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Zydelig (EU/UK/India)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.